Risk Factors for Recurrent Urinary Tract Infections in Diabetic Patients
Mohammed Ahmed Jumah, Ayed Abdullah Alshuaibi, Sarah hasan altwirgi, Awadh Mohammed Al Antar, Obaid Shabib Alotaibi, Jumana Ali Basowad, Zahra Ali Ghazwi, Lameer Adel Saleh, Fatemah saleh Alhajri, Waad Shabib AlotaibiRecurrent urinary tract infections are a frequent clinical problem in patients with diabetes mellitus and are associated with repeated antibiotic exposure, increased healthcare utilization, and a higher risk of complicated infection. Diabetes can increase susceptibility to recurrence through multiple interacting mechanisms, including persistent hyperglycemia, glucosuria, impaired innate immune responses, autonomic neuropathy, and incomplete bladder emptying. The risk is further influenced by patient characteristics such as age, sex, duration of diabetes, renal impairment, obesity, functional limitations, and previous urinary tract infections. Lifestyle and behavioral factors remain clinically relevant, particularly low fluid intake, delayed voiding, sexual activity, and spermicide exposure, although the strength of association varies between these factors. Medication can also modify recurrence patterns. Sodium-glucose cotransporter-2 inhibitors increase urinary glucose excretion, but their association with bacterial urinary tract infection is less consistent than their established relationship with genital infections. Repeated antimicrobial courses represent a separate concern because they may select resistant uropathogens and reduce the effectiveness of commonly used empirical treatments. Prevention therefore depends on identifying modifiable contributors rather than relying solely on repeated antibiotic therapy. Adequate hydration, regular bladder emptying, attention to sexual and contraceptive factors, optimization of glycemic control, and assessment of diabetic complications should form part of routine primary care management. In selected patients with frequent recurrences, continuous or postcoital antimicrobial prophylaxis, self-initiated treatment, methenamine hippurate, or vaginal estrogen in postmenopausal women may be considered according to individual clinical characteristics. Careful documentation of urine cultures, susceptibility profiles, recurrence frequency, renal function, and previous antimicrobial exposure can support more precise treatment decisions. A primary care approach that integrates diabetes management with infection prevention may reduce recurrence, limit unnecessary antimicrobial use, and improve long-term outcomes in patients experiencing repeated urinary tract infections.